Search

Your search keyword '"Fenton, G."' showing total 412 results

Search Constraints

Start Over You searched for: Author "Fenton, G." Remove constraint Author: "Fenton, G." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
412 results on '"Fenton, G."'

Search Results

2. Creating Schools as Learning Communities: Obstacles and Processes

Catalog

Books, media, physical & digital resources

3. Evaluation of surface disinfection methods to inactivate the beta coronavirus Murine Hepatitis Virus

7. Lgr5+ endogenous progenitor cells in the adult (deafened) cochlea.

8. Factors Affecting the Perceived Effectiveness of Planning in Hong Kong Self-Managing Schools.

9. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

10. Towards a Research Paradigm on Devolution.

14. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

15. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial

16. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

17. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

19. Long term expansion of Lgr5 positive supporting cells and differentiation into a hair cell-like phenotype from adult mouse derived cochlear organoids.

26. Development and validation of a targeted gene sequencing panel for application to disparate cancers

29. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

30. Experiences of higher education students on the autism spectrum: Stories of low mood and high resilience

36. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

39. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

40. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

48. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public